Francisco Purroy Selected Research

Carotid Stenosis (Carotid Artery Stenosis)

10/2013

Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco Purroy Research Topics

Disease

31	Stroke (Strokes) 04/2024 - 07/2005
11	Ischemic Stroke 04/2024 - 07/2005
6	Transient Ischemic Attack 01/2023 - 10/2012
4	Inflammation (Inflammations) 04/2024 - 01/2020
4	Prediabetic State (Prediabetes) 03/2022 - 11/2019
3	Coronary Disease (Coronary Heart Disease) 01/2023 - 02/2012
3	Ischemia 12/2021 - 07/2018
3	Embolic Stroke 06/2021 - 05/2015
3	Hemorrhage 01/2018 - 02/2014
2	Infarction (Infarctions) 11/2021 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 10/2021 - 07/2018
2	Diabetes Mellitus 10/2021 - 02/2014
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020 - 10/2019
2	Hypertension (High Blood Pressure) 01/2017 - 01/2016
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016 - 01/2016
2	Atherosclerosis 01/2015 - 12/2007
2	Cerebral Hemorrhage 02/2014 - 10/2012
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2023
1	Cerebral Infarction 01/2023
1	Hyperglycemia 03/2022
1	Lung Diseases (Lung Disease) 03/2022
1	Renal Insufficiency (Renal Failure) 10/2021
1	Seizures (Absence Seizure) 04/2021
1	Obesity 03/2021
1	Disease Progression 02/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2018
1	Cognitive Dysfunction 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Leukoaraiosis 01/2018
1	Siderosis 01/2018
1	Vascular Malformations 01/2016
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2013
1	Acute Coronary Syndrome 10/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2013
1	Peripheral Arterial Disease 02/2012
1	Hypercholesterolemia 02/2012
1	Carotid Artery Diseases 02/2006

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 11/2023 - 07/2013
4	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2022 - 07/2005
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2022 - 11/2019
2	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 11/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 10/2013
2	AnticoagulantsIBA 01/2018 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 02/2014
2	danaparoid (Orgaran)FDA Link 06/2013 - 12/2007
1	Fibrinogen (Factor I)FDA Link 04/2024
1	C-Reactive ProteinIBA 01/2023
1	Advanced Glycation End ProductsIBA 03/2022
1	Syntex adjuvant formulationIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	Oxygen (Dioxygen)IBA 03/2022
1	BarbituratesIBA 12/2021
1	Anesthetics (Anesthetic Agents)IBA 12/2021
1	InterleukinsIBA 06/2021
1	Colchicine FDA LinkGeneric 06/2021
1	Tubulin ModulatorsIBA 06/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Cytochrome P-450 CYP2C9IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	AcenocoumarolIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Uric Acid (Urate)IBA 11/2018
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2018
1	Natriuretic PeptidesIBA 05/2015
1	pro-brain natriuretic peptide (1-76)IBA 05/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2015
1	Blood Glucose (Blood Sugar)IBA 02/2014

Therapy/Procedure

12	Therapeutics 04/2024 - 02/2012
7	Secondary Prevention 04/2024 - 05/2015
7	Thrombectomy 04/2023 - 01/2014
2	General Anesthesia 01/2023 - 10/2021
2	Contraindications 11/2022 - 01/2014
2	Punctures 10/2021 - 01/2016
2	Time-to-Treatment 01/2016 - 02/2006
1	Ambulatory Care (Outpatient Care) 01/2017
1	Thrombolytic Therapy 10/2012
1	Microbubbles 02/2006